<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-271
Date of Submission: 2025-07-30

This report was submitted by a Nurse from Gonzales Group Medical Center concerning patient ANON-PX-8337. The subject is a 87-year-old male with a significant medical history including type 2 diabetes, osteoarthritis, hypertension, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Levothyroxine (Thyroid hormone) administered via the Intravenous route at a dosage of 393mg, initiated on 2025-05-09 for Hypothyroidism with the course ongoing.

On approximately 2025-06-12, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Vomiting, Anaphylaxis. The Nausea was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Vomiting was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed tonight and advised exist. The current patient status regarding this symptom is 'Not Recovered'. The Anaphylaxis was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed interest and advised think. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Born experience them protect project me. Present knowledge space in. Particularly while write teacher certainly figure toward.</data>
report_id: ADR-2025-271
report_date: '2025-07-30'
patient_details:
  patient_id: ANON-PX-8337
  gender: Male
  relevant_history:
  - type 2 diabetes
  - osteoarthritis
  - hypertension
  - migraines
  age_at_reaction: 87
suspected_drugs:
- drug_name: Levothyroxine
  dosage: 393mg
  route_of_administration: Intravenous
  start_date: '2025-05-09'
  indication_for_use: Hypothyroidism
  drug_class: Thyroid hormone
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2025-06-12'
  severity: Severe
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2025-06-12'
  severity: Mild
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed tonight and advised exist.
- symptom_name: Anaphylaxis
  onset_date: '2025-06-12'
  severity: Mild
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed interest and advised think.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Gonzales Group Medical Center
reporter_type: Nurse
notes: Born experience them protect project me. Present knowledge space in. Particularly
  while write teacher certainly figure toward.
